Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mesothelioma Malignant Advanced”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Testing effectiveness (Phase 2)Study completedNCT01204203
What this trial is testing

Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)

Who this might be right for
Mesothelioma
University of Alabama at Birmingham 8
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Testing effectiveness (Phase 2)Active Not RecruitingNCT03935893
What this trial is testing

Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+7 more
Udai Kammula 20
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Early research (Phase 1)Active Not RecruitingNCT04328844
What this trial is testing

Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

Who this might be right for
Solid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more
iOnctura 210
Early research (Phase 1)UnknownNCT04000906
What this trial is testing

PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Carcinomatosis
University Hospital, Geneva 18
Large-scale testing (Phase 3)Study completedNCT01098266
What this trial is testing

NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed

Who this might be right for
Malignant Pleural Mesothelioma
AGC Biologics S.p.A. 400
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT02610140
What this trial is testing

Phase II Anetumab Ravtansine as 2nd Line Treatment for Malignant Pleural Mesothelioma (MPM)

Who this might be right for
Mesothelioma
Bayer 248
Early research (Phase 1)Looking for participantsNCT05627960
What this trial is testing

First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

Who this might be right for
Triple Negative Breast CancerHormone-Resistant Breast CancerNon Small Cell Lung Cancer+1 more
A&G Pharmaceutical Inc. 77
Early research (Phase 1)Looking for participantsNCT06251310
What this trial is testing

SW-682 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMesothelioma, Malignant
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany 186
Testing effectiveness (Phase 2)Study completedNCT00024076
What this trial is testing

Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer

Who this might be right for
Lung CancerMalignant MesotheliomaMetastatic Cancer+1 more
Jonsson Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02628067
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Who this might be right for
Advanced CancerAnal CarcinomaAnal Cancer+22 more
Merck Sharp & Dohme LLC 1,609
Testing effectiveness (Phase 2)UnknownNCT04290325
What this trial is testing

HMPL-453 in Advanced Malignant Mesothelioma

Who this might be right for
Advanced Malignant Mesothelioma
Hutchison Medipharma Limited 27
Early research (Phase 1)Looking for participantsNCT06756035
What this trial is testing

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Who this might be right for
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Context Therapeutics Inc. 70
Testing effectiveness (Phase 2)Looking for participantsNCT05188859
What this trial is testing

First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma

Who this might be right for
Mesothelioma, MalignantMesothelioma, Malignant PleuralMesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 29
Very early researchUnknownNCT04489862
What this trial is testing

ΑPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

Who this might be right for
Non-small-cell Lung CancerMesothelioma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 10
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Load More Results